455 related articles for article (PubMed ID: 26432865)
1. High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells.
Ojo OO; Ryu MH; Jha A; Unruh H; Halayko AJ
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1354-66. PubMed ID: 26432865
[TBL] [Abstract][Full Text] [Related]
2. RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension.
Jia D; He Y; Zhu Q; Liu H; Zuo C; Chen G; Yu Y; Lu A
Cardiovasc Res; 2017 May; 113(6):586-597. PubMed ID: 28407046
[TBL] [Abstract][Full Text] [Related]
3. The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study.
Zhai R; Blondonnet R; Ebrahimi E; Belville C; Audard J; Gross C; Choltus H; Henrioux F; Constantin JM; Pereira B; Blanchon L; Sapin V; Jabaudon M
Exp Cell Res; 2020 Jun; 391(2):112030. PubMed ID: 32330509
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.
Sachdev U; Cui X; Tzeng E
J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695
[TBL] [Abstract][Full Text] [Related]
5. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
[TBL] [Abstract][Full Text] [Related]
6. The role of HMGB1/RAGE/TLR4 signaling pathways in cigarette smoke-induced inflammation in chronic obstructive pulmonary disease.
Lin L; Li J; Song Q; Cheng W; Chen P
Immun Inflamm Dis; 2022 Nov; 10(11):e711. PubMed ID: 36301039
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2.
Liang Y; Hou C; Kong J; Wen H; Zheng X; Wu L; Huang H; Chen Y
Mol Cell Biochem; 2015 Jul; 405(1-2):63-71. PubMed ID: 25862459
[TBL] [Abstract][Full Text] [Related]
8. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
[TBL] [Abstract][Full Text] [Related]
9. High mobility group box-1 induces pro-inflammatory signaling in human nucleus pulposus cells via toll-like receptor 4-dependent pathway.
Shah BS; Burt KG; Jacobsen T; Fernandes TD; Alipui DO; Weber KT; Levine M; Chavan SS; Yang H; Tracey KJ; Chahine NO
J Orthop Res; 2019 Jan; 37(1):220-231. PubMed ID: 30273982
[TBL] [Abstract][Full Text] [Related]
10. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
11. Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results.
Paudel YN; Angelopoulou E; Piperi C; Othman I; Shaikh MF
Pharmacol Res; 2020 Jun; 156():104792. PubMed ID: 32278047
[TBL] [Abstract][Full Text] [Related]
12. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.
Chandrashekaran V; Seth RK; Dattaroy D; Alhasson F; Ziolenka J; Carson J; Berger FG; Kalyanaraman B; Diehl AM; Chatterjee S
Redox Biol; 2017 Oct; 13():8-19. PubMed ID: 28551086
[TBL] [Abstract][Full Text] [Related]
13. Role of the high mobility group box 1 signalling axes via the receptor for advanced glycation end-products and toll-like receptor-4 in the immunopathology of oral lichen planus: a potential drug target?
Salem A; Almahmoudi R; Vehviläinen M; Salo T
Eur J Oral Sci; 2018 Jun; 126(3):244-248. PubMed ID: 29676511
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box-B1 (HMGB1) mediates the hypoxia-induced mesenchymal transition of osteoblast cells via activating ERK/JNK signaling.
Qiu Y; Chen Y; Zeng T; Guo W; Zhou W; Yang X
Cell Biol Int; 2016 Nov; 40(11):1152-1161. PubMed ID: 27106169
[TBL] [Abstract][Full Text] [Related]
15. Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting.
Paudel YN; Angelopoulou E; Piperi C; Othman I; Aamir K; Shaikh MF
Cells; 2020 Feb; 9(2):. PubMed ID: 32046119
[TBL] [Abstract][Full Text] [Related]
16. Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation.
Moraes TR; Veras FP; Barchuk AR; Nogueira ESC; Kanashiro A; Galdino G
Front Immunol; 2024; 15():1303937. PubMed ID: 38384464
[TBL] [Abstract][Full Text] [Related]
17. Ectodomain Shedding of RAGE and TLR4 as a Negative Feedback Regulation in High-Mobility Group Box 1-Activated Aortic Endothelial Cells.
Yang WS; Kim JJ; Lee MJ; Lee EK; Park SK
Cell Physiol Biochem; 2018; 51(4):1632-1644. PubMed ID: 30497069
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
19. High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway.
Huang W; Zhao H; Dong H; Wu Y; Yao L; Zou F; Cai S
Int J Mol Med; 2016 May; 37(5):1189-98. PubMed ID: 27035254
[TBL] [Abstract][Full Text] [Related]
20. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway.
Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z
Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
